540 Chemie und zugeordnete Wissenschaften
Refine
Has Fulltext
- yes (18)
Is part of the Bibliography
- yes (18)
Year of publication
- 2015 (18) (remove)
Document Type
- Doctoral Thesis (17)
- Journal article (1)
Language
- English (18) (remove)
Keywords
- Ladungstransfer (3)
- Aggregation (2)
- Exziton (2)
- Fotoionisation (2)
- Molekulardynamik (2)
- Pyrolyse (2)
- Selbstorganisation (2)
- Ultraviolett-Photoelektronenspektroskopie (2)
- antileishmanial (2)
- charge transfer (2)
Institute
Sonstige beteiligte Institutionen
- Novartis AG (1)
ResearcherID
- B-1911-2015 (1)
- N-3741-2015 (1)
The chloroform extract of Valeriana wallichii (V. wallichii) rhizomes was investigated to elucidate the structures responsible for reported antileishmanial activity. Besides bornyl caffeate (1, already been reported by us previously), bioassay-guided fractionation resulted in two additional cinnamic acid derivatives 2–3 with moderate leishmanicidal activity. The structure of a novel nepetolactone derivative 4 having a cinnamic acid moiety was elucidated by means of spectral analysis. To the best of our knowledge villoside aglycone (5) was isolated from this plant for the first time. The bioassay-guided fractionation yielded two new (compounds 6–7) and two known valtrates (compounds 8–9) with leishmanicidal potential against Leishmania major (L. major) promastigotes. In addition, β-bisabolol (10), α-kessyl alcohol (11), valeranone (12), bornyl isovalerate (13) and linarin-2-O-methylbutyrate (14) were identified. This is the first report on the isolation of 4'-demethylpodophyllotoxin (15), podophyllotoxin (16) and pinoresinol (17) in V. wallichii. In total thirteen known and four new compounds were identified from the extract and their cytotoxic and antileishmanial properties were evaluated.
Intraperitoneal adhesions are fibrous bands that connect tissues in the peritoneal cavity that are usually separated. These adhesions form as a consequence of trauma, inflammation or surgical interventions and often result in severe consequences such as chronic pain, small bowel obstructions or female infertility.
The aim of this thesis was to develop a synthetic barrier device for adhesion prevention made of modified poly(lactide) [PLA]. Solid PLA films (SurgiWrap®) are already successfully in clinical use due to the good biocompatibility and the biodegradability of the material resulting in non-toxic degradation products since lactic acid is naturally part of the metabolic circles of the human body. Considering the brittleness and stiffness of the films, the long degradation time of several months as well as the need for suturing, there is potential for optimization. Through a copolymerization with the hydrophilic poly(ethylene glycol) [PEG], a reduction of the degradation time was intendend. Moreover, the copolymerization should also lead to an improvement of the mechanical properties of the films since PEG acts as plasticizer for PLA. Linear PLA-PEG-PLA triblock copolymers as well as star-shaped PEG-PLA copolymers were synthesized via standard ring opening polymerization to tailor the barrier properties. Besides solid films, solution electrospun meshes from PLA and the synthesized PEG-PLA copolymers were investigated for a potential application as well. Since suturing of a barrier additionally induces adhesion formation, alginate coated membranes were prepared in order to achieve self-adhesiveness. With the intention to reduce infections and consequently inflammation, electrospun meshes and solvent cast films were loaded with the antibacterial drug triclosan and drug release as well as antibacterial efficacy was investigated.
Mechanical tests confirmed that through the variation of the PEG content and branching the mechanical properties can be tailored and are in good accordance with the glass transition temperatures [Tg] of the polymers. Consequently, potentially adequate mechanical properties for surgical handling as well as for the performance within the patient’s body were successfully achieved. Degradation studies revealed that the degradation time was significantly shorter for PEG-PLA membranes than for PLA films and with an appropriate PEG content could be adjusted to the intended time frame. Cell adhesion and viability tests confirmed the non-toxicity of the clinically used PLA films as well as of PEG-PLA films and meshes. With a bioadhesion test the benefit of an alginate coated side towards the pure PLA film concerning self-adhesiveness was successfully demonstrated. Moreover, optical evaluations and a T-peel test of different alginate coated PLA films showed that the cohesion between the chemically different layers was distinctly enhanced by the use of an appropriate PEG-PLA mesh as intermediate cohesion promoting layer. In in vitro release studies with triclosan loaded films a higher release was determined for PEG-PLA than for PLA films. In agar diffusion tests a higher and longer inhibition of staphylococcus aureus growth was observed confirming the release results. Moreover, drug loaded meshes (especially drug loaded after electrospinning) showed enhanced and elongated bacterial inhibition in comparison to films.
\textbf{Molecular Determinants of Drug-Target Residence Times of Bacterial Enoyl-ACP Reductases.} Whereas optimization processes of early drug discovery campaigns are often affinity-driven, the drug-target residence time $t_R$ should also be considered due to an often strong correlation with \textit{in vivo} efficacy of compounds. However, rational optimization of $t_R$ is not straightforward and generally hampered by the lack of structural information about the transition states of ligand association and dissociation. The enoyl-ACP reductase FabI of the fatty acid synthesis (FAS) type II is an important drug-target in antibiotic research. InhA is the FabI enzyme of \textit{Mycobacterium tuberculosis}, which is known to be inhibited by various compound classes. Slow-onset inhibition of InhA is assumed to be associated with the ordering of the most flexible protein region, the substrate binding loop (SBL). Diphenylethers are one class of InhA inhibitors that can promote such SBL ordering, resulting in long drug-target residence times. Although these inhibitors are energetically and kinetically well characterized, it is still unclear how the structural features of a ligand affect $t_R$.
Using classical molecular dynamics (MD) simulations, recurring conformational families of InhA protein-ligand complexes were detected and structural determinants of drug-target residence time of diphenyl\-ethers with different kinetic profiles were described. This information was used to deduce guidelines for efficacy improvement of InhA inhibitors, including 5'-substitution on the diphenylether B-ring. The validity of this suggestion was then analyzed by means of MD simulations.
Moreover, Steered MD (SMD) simulations were employed to analyze ligand dissociation of diphenylethers from the FabI enzyme of \textit{Staphylococcus aureus}. This approach resulted in a very accurate and quantitative linear regression model of the experimental $ln(t_R)$ of these inhibitors as a function of the calculated maximum free energy change of induced ligand extraction. This model can be used to predict the residence times of new potential inhibitors from crystal structures or valid docking poses.
Since correct structural characterization of the intermediate enzyme-inhibitor state (EI) and the final state (EI*) of two-step slow-onset inhibition is crucial for rational residence time optimization, the current view of the EI and EI* states of InhA was revisited by means of crystal structure analysis, MD and SMD simulations. Overall, the analyses affirmed that the EI* state is a conformation resembling the 2X23 crystal structure (with slow-onset inhibitor \textbf{PT70}), whereas a twist of residues Ile202 and Val203 with a further opened helix $\alpha 6$ corresponds to the EI state. Furthermore, MD simulations emphasized the influence of close contacts to symmetry mates in the SBL region on SBL stability, underlined by the observation that an MD simulation of \textbf{PT155} chain A with chain B' of a symmetry mate in close proximity of the SBL region showed significantly more stable loops, than a simulation of the tetrameric assembly. Closing Part I, SMD simulations were employed which allow the delimitation of slow-onset InhA inhibitors from rapid reversible ligands.
\textbf{Prediction of \textit{Mycobacterium tuberculosis} Cell Wall Permeability.} The cell wall of \textit{M. tuberculosis} hampers antimycobacterial drug design due to its unique composition, providing intrinsic antibiotic resistance against lipophilic and hydrophilic compounds. To assess the druggability space of this pathogen, a large-scale data mining endeavor was conducted, based on multivariate statistical analysis of differences in the physico-chemical composition of a normally distributed drug-like chemical space and a database of antimycobacterial--and thus very likely permeable--compounds. The approach resulted in the logistic regression model MycPermCheck, which is able to predict the permeability probability of small organic molecules based on their physico-chemical properties. Evaluation of MycPermCheck suggests a high predictive power. The model was implemented as a freely accessible online service and as a local stand-alone command-line version.
Methodologies and findings from both parts of this thesis were combined to conduct a virtual screening for antimycobacterial substances. MycPermCheck was employed to screen the chemical permeability space of \textit{M. tuberculosis} from the entire ZINC12 drug-like database. After subsequent filtering steps regarding ADMET properties, InhA was chosen as an exemplary target. Docking to InhA led to a principal hit compound, which was further optimized. The quality of the interaction of selected derivatives with InhA was subsequently evaluated using MD and SMD simulations in terms of protein and ligand stability, as well as maximum free energy change of induced ligand egress. The results of the presented computational experiments suggest that compounds with an indole-3-acethydrazide scaffold might constitute a novel class of InhA inhibitors, worthwhile of further investigation.
The aim of the present work is the development and implementation of new simulation
possibilities for the CAST program package. Development included, among other
things, the partial parallelization of the already existing force fields, extension of the
treatment of electrostatic interactions and implementation of molecular dynamics and
free energy algorithms.
The most time consuming part of force field calculations is the evaluation of the nonbonded
interactions. The calculation of these interactions has been parallelized and
it could be shown to yield a significant speed up for multi-core calculations compared
to the serial execution on only one CPU. For both, simple energy/gradient as well as
molecular dynamics simulations the computational time could be significantly reduced.
To further increase the performance of calculations employing a cutoff radius, a linkedcell
algorithm was implemented which is able to build up the non-bonded interaction
list up to 7 times faster than the original algorithm.
To provide access to dynamic properties based on the natural time evolution of a system,
a molecular dynamics code has been implemented. The MD implementation features
two integration schemes for the equations of motion which are able to generate stable
trajectories. The basic MD algorithm as described in Section 1.2 leads to the sampling
in the microcanonical (NVE) ensemble. The practical use of NVE simulations is limited
though because it does not correspond to any experimentally realistic situation.
More realistic simulation conditions are found in the isothermal (NVT) and isothermalisobaric
(NPT) ensembles. To generate those ensembles, temperature and pressure
control has been implemented. The temperature can be controlled in two ways: by direct
velocity scaling and by a Nose-Hoover thermostat which produces a real canonical
ensemble. The pressure coupling is realized by implementation of a Berendsen barostat.
The pressure coupling can be used for isotropic or anisotropic box dimensions with the
restriction that the angles of the box need to be 90. A crucial simulation parameter in
MD simulations is the length of the timestep. The timestep is usually in the rang of 1fs.
Increasing the timestep beyond 1fs can lead to unstable trajectories since the fastest
motion in the system, usually the H-X stretch vibration can not be sampled anymore.
A way to allow for bigger timesteps is the use of a constraint algorithm which constrains the H-X bonds to the equilibrium distance. For this the RATTLE algorithm has been
implemented in the CAST program. The velocity Verlet algorithm in combination with
the RATTLE algorithm has been shown to yield stable trajectories for an arbitrary
length of simulation time. In a first application the MD implementation is used in conjunction
with the MOPAC interface for the investigation of PBI sidechains and their
rigidity. The theoretical investigations show a nice agreement with experimentally obtained
results. Based on the MD techniques two algorithms for the determination of free
energy differences have been implemented. The umbrella sampling algorithm can be
used to determine the free energy change along a reaction coordinate based on distances
or dihedral angles. The implementation was tested on the stretching of a deca-L-alanine
and the rotation barrier of butane in vacuum. The results are in nearly perfect agreement
with literature values. For the FEP implementation calculations were performed
for a zero-sum transformation of ethane in explicit solvent, the charging of a sodium
ion in explicit solvent and the transformations of a tripeptide in explicit solvent. All
results are in agreement with benchmark calculations of the NAMD program as well
as literature values. The FEP formalism was then applied to determine the relative
binding free energies between two inhibitors in an inhibitor-protein complex.
Next to force fields, ab-initio methods can be used for simulations and global optimizations.
Since the performance of such methods is usually significantly poorer than force
field applications, the use for global optimizations is limited. Nevertheless significant
progress has been made by porting these codes to GPUs. In order to make use of these
developments a MPI interface has been implemented into CAST for communication
with the DFT code TeraChem. The CAST/TeraChem combination has been tested
on the $H_2 O_{10}$ cluster as well as the polypeptide met-Enkephalin. The pure ab-initio
calculations showed a superior behavior compared to the standard procedure where the
force field results are usually refined using quantum chemical methods.
Dietary polyphenols have been related to beneficial effects on humans’ health. Pycnogenol®, a dietary polyphenol-rich food supplement complies with the monograph “Maritime pine extract” in the United States Pharmacopeia (USP) and has demonstrated effects in different diseases. Several human trials concerning knee osteoarthritis have shown significant improvement of the symptoms like reducing the pain and the stiffness of the joint(s) upon intake of Pycnogenol®. After oral intake of multiple doses of Pycnogenol® previously low concentrations in the nanomolar range of monomeric extract constituents have been found in human plasma as well as a bioactive metabolite, δ-(3,4-dihydroxy-phenyl)-γ-valerolactone (M1), which is formed by the human intestinal flora from the procyanidins’ catechin units. It is not clear yet which compound(s) of the complex extract is (are) mainly responsible for the described clinical effects of Pycnogenol®. To gain deeper insights into the in vivo fate of the pine bark extract the distribution of its constitutents and metabolites was closer investigated in the present thesis.
Initial in vitro experiments suggested a facilitated cellular uptake of M1 into human erythrocytes, possibly via GLUT-1 transporter. For elucidating further the in vitro and in vivo metabolism of M1 in human blood cells, a metabolomic approach was performed using UPLC-ESI-qTOF-MSE analysis, which revealed a comprehensive and rapid metabolism of M1 to a variety of biotransformation products in human blood cells. Predominant metabolites were found to be conjugates of glutathione (GSH) isomers, namely M1-S-GSH and M1-N-GSH. Further sulfur-containing biotransformation products of M1 were conjugates with oxidized glutathione (M1-GSSG) and cysteine (M1-CYS) and the sulfated derivative of M1 (M1-sulfated). Other in vitro biotransformation products constituted the open-chained ester form of M1 (M1-COOH), hydroxybenzoic acid and the methylated (M1-methylated), acetylated (M1-acetylated), hydroxylated (M1-hydroxylated) and ethylated (M1-ethylated) derivatives of M1. Indeed, six of these in vitro metabolites, respectively M1-COOH, M1-sulfated, hydroxybenzoic acid, M1-S-GSH, M1-methylated and M1-acetylated, were also identified in vivo in blood cells of human volunteers after ingestion of Pycnogenol®. Related reference material was synthesized for reliable confirmation of the metabolites M1-GSH, M1-GSSG, M1-CYS and M1-COOH.
In the course of a randomized controlled clinical trial patients suffering from severe osteoarthritis ingested multiple doses of 200 mg/day Pycnogenol® for three weeks before they were scheduled for an elective knee replacement surgery. Various biological specimen, respectively blood cells, synovial fluid and serum samples, were to be analyzed to investigate the distribution and disposition of possibly bioactive constituents and metabolites. Therefore, highly sensitive methods were developed using liquid chromatography tandem mass spectrometry (LC-MS/MS)- technology because of the expected low concentrations of the analytes in the related matrices.
Initially, for each matrix different sample preparation techniques (protein precipitation, liquid-liquid extraction, solid phase extraction and useful combinations thereof) were compared to achieve maximum detection sensitivity of the analytes that were of highest interest, namely M1, ferulic acid and taxifolin. By comparing 32 various sample clean-up procedures in human serum, the highest recovery of the metabolite M1 was achieved using a liquid-liquid extraction with ethyl acetate and tert-butyl methyl ether at a serum pH-value of 3.2. A similar extraction method was also chosen for analyte detection in human synovial fluid after comparing 31 different sample preparation techniques. Whole blood or blood cells are difficult to handle because of their high viscosity and strong coloration. The QuEChERS (quick, easy, cheap, effective, rugged and safe) approach which was originally developed for the food safety and thus for the determination of pesticide residues in fruits and vegetables yielded the highest total recovery rate of M1 in human blood cells when assessing 18 different sample clean-up techniques. By applying the QuEChERS method for the first time for the simultaneous and highly sensitive quantification of selected polyphenols in human blood cells it was demonstrated that this fast and inexpensive technique can be applied in clinical fields for cleaning-up highly complex and thus challenging biological matrices. All developed methods for the different biological specimen were optimized to achieve maximum sensitivity of the target analytes. The determined lower limits of quantification (LLOQs) were sufficient for the quantification of the study samples. The LLOQs ranged from 113 pg/mL for taxifolin to 48 ng/mL for caffeic acid in blood cells and from 80 pg/mL for taxifolin to 3 ng/mL for caffeic acid in synovial fluid. In human serum the LLOQs even ranged down to 35 pg/mL for taxifolin and up to 8 ng/mL for caffeic acid. All analytical methods were subjected to a full validation according to current EMA and FDA guidelines and fulfilled those criteria, showing excellent performance and reliability of the developed and optimized methods.
Serum, blood cells and synovial fluid samples of the osteoarthritis patients were all processed with an enzymatic incubation with ß-glucuronidase/sulfatase to hydrolyse conjugates (phase-II-metabolism) prior the actual sample preparation. Additionally, serum samples of the osteoarthritis patients were prepared without enzymatic hydrolysis to determine the individual degree of conjugation with sulfate and glucuronic acid of the analytes.
All determined concentrations in the patients’ samples were in the lower ng/mL range. Notably, highest total concentrations of the polyphenols were not detected in serum, in which the degree of analyte conjugation with sulfate and glucuronic acid ranged from 54.29 ± 26.77% for catechin to 98.34 ± 4.40% for M1. The flavonoids catechin and taxifolin mainly partitioned into blood cells, whereas the metabolite M1, ferulic and caffeic acid primarily resided in the synovial fluid. The concentration of M1 in the blood cells was low, however, this could be explained by the previously observed extensive and rapid intracellular metabolism in vitro. This was now supported by the in vivo evidence in samples of patients who received Pycnogenol® in which the open-chained ester form of M1 (M1-COOH) as well as the glutathione conjugate of M1 (M1-GSH) were identified, indicating that M1 does not accumulate in its original form in vivo. Possibly, a variety of bioactive metabolites exist which might play an important role for the clinical effects of Pycnogenol®.
Although the study participants were requested to avoid polyphenol-rich food and beverages within the last two days before the blood samplings this was obviously difficult for most of the patients. Hence, no statistically significantly difference was observed in the mean polyphenol concentrations in serum, blood cells and synovial fluid between the intervention and the control group. Nevertheless, it was possible to identify marker compounds for Pycnogenol® intake under real life conditions with occasional or regular consumption of polyphenol-rich foods and beverages. Thereby, ferulic acid was found in serum samples exclusively after intake of Pycnogenol®, confirming that ferulic acid is a suitable marker of consumption of French maritime pine bark extract. Taxifolin was present in serum and synovial fluid exclusively in the intervention group indicating a role as further marker of Pycnogenol® intake. Taxifolin, ferulic acid and caffeic acid were detected in both serum and synovial fluid only in the intervention group. Moreover, the metabolite M1, taxifolin and ferulic acid were only detected simultaneously in all matrices (serum, blood cells and synovial fluid) after ingestion of Pycnogenol®.
Thus, deeper insights into the distribution of bioactive constituents and metabolites of Pycnogenol® into serum, blood cells and synovial fluid after oral administration to patients with severe osteoarthritis were gained. The present study provides the first evidence that polyphenols indeed distribute into the synovial fluid of patients with osteoarthritis where they might contribute to clinical effects.
The successful synthesis of a family of donor-iridium complex-acceptor triads (T1–T6, pMV1 and mMV1) and their electrochemical and photophysical properties were presented in this work. Triarylamines (TAA) were used as donors and naphthalene diimide (NDI) as acceptor. A bis-cyclometalated phenylpyrazole iridium dipyrrin complex acts as a photosensitiser. In addition, a molecular structure of T1 was obtained by single crystal X-ray diffraction.
Transient absorption spectroscopy experiments of these triads resembled that upon excitation a photoinduced electron transfer efficiently generates long-lived, charge-separated (CS) states. Thereby, the electron-transfer mechanism depends on the excitation energy.
The presence of singlet and triplet CS states was clarified by magnetic-field dependent transient-absorption spectroscopy in the nanosecond time regime. It was demonstrated that the magnetic field effect of charge-recombination kinetics showed for the first time a transition from the coherent to the incoherent spin-flip regime.
The lifetime of the CS states could be drastically prolonged by varying the spacer between the iridium complex and the NDI unit by using a biphenyl instead of a phenylene unit in T4.
A mixed-valence (MV) state of two TAA donors linked to an iridium metal centre were generated upon photoexcitation of triad pMV1 and mMV1. The mixed-valence character in these triads was proven by the analysis of an intervalence charge-transfer (IV-CT) band in the (near-infrared) NIR spectral region by femtosecond pump-probe experiments. These findings were supported by TD-DFT calculations.
The synthesis of dyads (D1–D4) was performed. Thereby the dipyrrin ligand was substituted with electron withdrawing groups. The electrochemical and photophysical characterisation revealed that in one case (D4) it was possible to generate a CS state upon photoexcitation.
The focus of this work was the investigation of energy transfer between charge transfer states. For this purpose the multidimensional chromophores HAB-S, HAB-A, B1 and B2 were synthesised, each consisting of three electron donor and three electron acceptor redox centres linked symmetrically or asymmetrically by the hexaarylbenzene framework. Triarylamines represent in all these compounds the electron donors, whereas the electron poor centres were triarylboranes in B1 and B2 and PCTM centres in HAB-S and HAB-A, respectively. The hexaarylbenzenes were obtained by cobalt catalysed cyclotrimerisation of the respective tolan precursors. In addition, Star was synthesised, which consists of a central PCTM linked to three triarylamin centres by tolan bridging units in a star-like configuration. The hexaarylbenzene S1a/b substituted with six squaraine chromophores could not be realised. It is assumed that the cyclotrimerisation catalyst Co2(CO)8 does not tolerate the essential hydroxyl groups in the tolan precursor S2a. The alternative reaction pathway to execute the cyclotrimerisation reaction first and introduce the hydroxyl groups thereafter failed as well, because the required hexaarylbenzene substituted by six semisquaric acid moieties could not be synthesised. However, energy transfer interactions could be investigated in the tolan precursor S2a with two squaraine units to obtain information about the electronic coupling provided by the tolan bridge. For all multidimensional compounds model molecules were synthesised with only a single donor-acceptor pair (B3, Star-Model and HAB-Model). This allows a separate consideration of energy and charge transfer processes. It has to be stressed that in all before mentioned multidimensional compounds the “through bond” energy transfer interaction between neighbouring IV-CT states is identical to a transfer of a single electron between two redox centres of the same kind (e.g. TAA -> TAA+). The latter can be analysed by electron transfer theory. This situation is observed when the two IV-CT states transferring energy share one redox centre.
All compounds containing PCTM centres were characterised by paramagnetic resonance spectroscopy. Thereby, a weak interaction between the three PCTM units in HAB-S and HAB-A was observed. In addition, when oxidising Star-Model, a strongly interacting singlet or triplet state was obtained. In contrast, signals corresponding to a weakly interacting biradical were obtained for HAB-Model+. This indicates a strong electronic coupling between the redox centres provided by the tolan bridge and a weak coupling when linked by the hexaarylbenzene. This trend is supported by UV/Vis/NIR absorption measurements. The analysis of the observed IV-CT absorption bands by electron transfer theory reveals a weak electronic coupling of V = 340 cm-1 in HAB-Model and a distinctly stronger coupling of V = 1190-2900 cm-1 in Star-Model. In the oxidised HAB-S+, Star+ and Star-Model+ a charge transfer reversed from that of the neutral species, that is, from the PCTM radical to the electron poorer cationic TAA centre, was observed by spectroelectrochemistry. The temporal evolution of the excited states was monitored by ultrafast transient absorption measurements. Within the first picosecond stabilisation of the charge transfer state was observed, induced by solvent rotation. Anisotropic transient absorption measurements revealed that within the lifetime of the excited state (tau = 1-4 ps) energy transfer does not occur in the HABs whereas in the star-like system ultrafast and possibly coherent energy redistribution is observed. Taken this information together the identity between energy transfer and electron transfer in the specific systems were made apparent. It has to be remarked that neither energy transfer nor charge transfer theory can account for the very fast energy transfer in Star.
The electrochemical and photophysical properties of B1 and B2 were investigated by cyclic voltammetry, absorption and fluorescence measurements and were compared to B3 with only one neighbouring donor-acceptor pair. For the asymmetric B2 CV measurements show three oxidations as well as three reduction peaks whose peak separation is greatly influenced by the conducting salt due to ion-pairing and shielding effects. Consequently, peak separations cannot be interpreted in terms of electronic couplings in the generated mixed valence species. Transient absorption, fluorescence solvatochromism and absorption spectra show that charge transfer states from the amine to the boron centres are generated after optical excitation. The electronic donor-acceptor interaction is weak though as the charge transfer has to occur predominantly through space. The electronic coupling could not be quantified as the CT absorption band is superimposed by pi-pi* transitions localised at the amine and borane centres. However, this trend is in good agreement to the weak coupling measured for HAB-Model. Both transient absorption and fluorescence upconversion measurements indicate an ultrafast stabilisation of the charge transfer state in B1- B3 similar to the corresponding observations in HAB-S and Star. Moreover, the excitation energy of the localised excited charge transfer states can be redistributed between the aryl substituents of these multidimensional chromophores within fluorescence lifetime (ca. 60 ns). This was proved by steady state fluorescence anisotropy measurements, which further indicate a symmetry breaking in the superficially symmetric HAB. Anisotropic fluorescence upconversion measurements confirm this finding and reveal a time constant of tau = 2-3 ps for the energy transfer in B1 and B2. It has to be stressed that, although the geometric structures of B1 and HAB-S are both based on the same framework and furthermore the neighbouring CT states show in both cases similar Coulomb couplings and negligible “through bond” couplings, very fast energy transfer is observed in B1 whereas in HAB-S the energy is not redistributed within the excited state lifetime. To explain this, it has to be kept in mind that the energy transfer and the relaxation of the CT state are competing processes. The latter is influenced moreover by the solvent viscosity. Hence, it is assumed that this discrepancy in energy transfer behaviour is caused by monitoring the excited state in solvents of varying viscosity. Adding fluoride ions causes the boron centres to lose their acceptor ability due to complexation. Consequently, the charge transfer character in the donor-acceptor chromophores vanishes which could be observed in both the absorption and fluorescence spectra. However, the fluoride sensor ability of the boron centre is influenced strongly by the moisture content of the solvent possibly due to hydrogen bonding of water to the fluoride anions.
UV/Vis/NIR absorption measurements of S2a show a red-shift by 1800 cm-1 of the characteristic squarain band compared to the model compound S20. From exciton theory a Coulomb coupling of V = 410 cm-1 is calculated which cannot account for this strong spectral shift. Consequently, “through-bond” interactions have to contribute to the strong communication between the two squaraine chromophores in S2a. This is in accordance with the strong charge transfer coupling calculated for the tolan spacer in Star-Model.
The scope of computational chemistry can be broadened by developing new methods and more efficient algorithms. However, the evaluation of the applicability of the methods for the different fields of chemistry is equally important. In this thesis systems with an unusual and complex electronic structure, such as excitonic states in organic semiconductors, a boron-containing bipolaron and the excited states of pyracene were studied and the applicability of the toolkit of computational chemistry was investigated. Concerning the organic semiconductors the focus was laid on organic solar cells, which are one of the most promising technologies with regard to satisfying the world's need for cheap and environmentally sustainable energy. This is due to the low production and material costs and the possibility of using flexible and transparent devices. However, their efficiency does still not live up to the expectations. Especially the exciton diffusion lengths seem to be significantly too short. In order to arrive at improved modules, a fundamental understanding of the elementary processes occurring in the cell on the molecular and supramolecular level is needed. Computational chemistry can provide insight by separating the different effects and providing models for predictions and prescreenings. In this thesis, the focus was laid on the description of excitonic states in merocyanines and perylene-based dyes taking the influence of the environment into account.
At first, the photochemical isomerization between two configurations of 6-nitro BIPS observed experimentally was studied by first benchmarking several functionals against SCS-ADC(2) in the gas phase and subsequently calculating the excited-state potential energy surface. The geometries obtained from a relaxed scan in the ground state as well as from a scan in the excited state were used. The environment was included using different polarizable continuum models. It was shown that the choice of the model and especially the question of the state specificity of the approach is of vital importance. Using the results of the calculations, a two-dimensional potential energy surface could be constructed that could be used to explain the experimental findings. Furthermore, the importance of the excited-state isomerization as a potential deactivation channel in the exciton transport was pointed out.
Then the assessment of the suitability of different merocyanines for optoelectronic applications with quantum-chemical methods was discussed. At first, the effect of the environment on the geometry, especially on the bond length alternation pattern, was investigated. It was shown that the environment changes the character of the ground-state wave function of several merocyanines qualitatively, which means that the results of gas-phase calculations are meaningless - at least when a comparison with solution or device data is desired. It was demonstrated that using a polarizable continuum model with an effective epsilon, a qualitative agreement between the calculated geometry and the geometry in the crystal structure can be obtained. Therefore, by comparing the bond length alternation in solution and in the crystal, a rough estimate of the effect of the crystal environment can be made.
It was further shown that the connection between the HOMO energy and the open-circuit voltage is not as simple as it is often implied in the literature. It was discussed that it is not clear whether the HOMO of a single molecule or a $\pi$-stack containing several monomers should be used and if the environmental charges of the bulk phase or the interface should be included. Investigating the dependence of the HOMO energy on the stack size yielded no definitive trend. Furthermore, it was discussed that the effect due the optimization of the modules (solvent, bulk heterojunction) during the production masks any potential correlation between the HOMO energy and measured open-circuit values. Therefore, a trend can only be expected for unoptimized bilayer cells. It was concluded that ultimately, the importance of the HOMO energy should not be overestimated.
The correlation between the exciton reorganization energy and the so-called cyanine limit, which is predicted by a simple two-state model, was also discussed. By referring to the results of VB calculations, it was discussed that the correlation indeed exists and is non-negligible, although the effect is not as strong as one might have expected. In this context, a potential application of a VB/MM approach was covered briefly. The importance of the molecular reorganization energy and the device morphology was also discussed.
It was concluded that the optimization of merocyanines for organic optoelectronic devices is inherently a multiparameter problem and one cannot expect to find one particular parameter, which solely controls the efficiency.
The perylene-based dyes were studied with a focus on the description of a potential trapping mechanism involving an intermolecular motion in a dimer. The aim was to find methods which can be applied to larger model systems than a dimer and take the effect of the environment into account. As a test coordinate the longitudinal shift of two monomers against each other was used. At first, it was demonstrated how the character of an excited state in a dimer can be defined and how it can be extracted from a standard quantum-chemical calculation. Then several functionals were benchmarked and their applicability or failure was rationalized using the character analysis. Two recipes could be proposed, which were applied to a constraint optimization (only intermolecular degrees of freedom) in the excited states of the PBI dimer and to the description of the potential energy surfaces of ground and excited states along a longitudinal displacement in the perylene tetramer, respectively.
It was further demonstrated that the semi-empirical OMx methods fail to give an accurate description of the excited-state potential energy surfaces as well as the ground-state surface along the test coordinate. This failure could be attributed to an underestimation of overlap-dependent terms. Consequently, it could be shown that the methods are applicable to large intermolecular distances, where the overlap is negligible. The results of DFT calculations with differently composed basis sets suggested that adding an additional single p-function for each atom should significantly improve the performance.
QM/MM methods are ideally suited to take the effect of the environment on a a dimer model system into account. However, it was shown that standard force fields also give an incorrect description of the interaction between the monomers along the intermolecular coordinate. This failure was attributed to the isotropic atom-atom interaction in the repulsion term of the Lennard-Jones potential. This was corroborated using two simple proof-of-principle anisotropy models. Therefore, a novel force field called OPLS-AA_O was presented that is based on OPLS-AA, but uses an anisotropic model for the repulsion. The model involves the overlap integral between the molecular densities, which are modeled as a sum of atom-centered p-type Gaussian functions. It was shown that using this force field an excellent agreement with the DFT results can be obtained when the correct parameters are used. These parameters, however, are not very generalizable, which was attributed to the simplicity of the model in its current state (using the same exponential parameter for all atoms). As a short excursion, the applicability of an MO-based overlap model was discussed.
It was demonstrated that the repulsion term based on the density overlap can be used to correct the failure of the OMx methods for the ground states. This is in accord with the assumption that an underestimation of the overlap terms is responsible for the failure.
It was shown that OPLS-AA_O also gives an excellent description of the longitudinal shift in a PBI tetramer. Using the tetramer as a test system and applying the recipe obtained in the TDDFT benchmark for the QM-part and OPLS-AA_O for the MM-part in conjunction with an electrostatic embedding scheme, a QM/MM description of the excited states of the PBI dimer including the effect of the environment could be obtained.
In the last chapter the theoretical description of the Bis(borolyl)thiophene dianion and the excited states of pyracene were discussed. The electronic structure of the Bis(borolyl)thiophene dianion - a negative bipolaron - was elucidated using DFT and CASPT2 methods. Furthermore, an estimation of the extent of triplet admixture to the ground state due to spin-orbit coupling was given.
In the second project the S1 and S2 states of pyracene were computed using SCS-CC2 and SCS-ADC(2) and an estimation for the balance between aromaticity and ring strain was given. This also involved computing the vibrational frequencies in the excited states.
In both studies the results of the computations were able to rationalize and complete experimental results.
Lattice forces are based on the attraction between the single moieties of molecules. The strength of lattice forces has an impact on the solid state and related physical properties such as melting point, boiling point, vapor pressure solvation and solubility. For solvation to occur, energy is required to break the lattice forces attracting ions and molecules among themselves. The energy for breaking up the attraction between the molecules is gained from the energy released when ions or molecules of the lattice associate with molecules of the solvent. Solubility is therefore, directly linked to the energy which is required to break the lattice forces and the energy which is liberated by solvation of the molecules or ions. Based on this relation, the lattice forces in two acidic compounds and a neutral compound were subsequently lowered by different approaches with the intention to increase the solubility, supersaturation, and dissolution rate.
The conversion to an ionic liquid and the embedding of the compound in a pH-sensitive matrix in an amorphous state were investigated with an acidic compound and its pro-drug. The tetrabutylphosphonium (TBPH) salt showed the most promising properties among the tested counter ions. It alters the properties of the compound from a highly crystalline physicochemical state to an amorphous readily soluble material showing supersaturation in a wider pH range and higher solubility than the sodium and potassium salts. A solid dispersion approach was developed in parallel. Solid dispersions with two different pH-sensitive polymers and different drug load were prepared by lyophilization to determine the miscibility of the compound and the polymer by differential scanning calorimetry (DSC). A miscibility of 50% of the amorphous acid with the pH-sensitive Eudragit L100-55 matrix and a miscibility of 40% with hydroxypropyl methylcellulose acetate succinate (HPMC-AS) was found. Both approaches, the TBPH salt and the solid dispersion based on the pH-sensitive Eudragit L100-55 were tested in vivo. The TBPH salt was dosed in a buffered solution to prevent precipitation in the acidic stomach pH. This resulted in BAV higher than the crystalline suspension but lower than the solid dispersion. There were no acute toxicology effects seen. Thus, TBPH was considered safe for further studies. The TBPH salts were very hygroscopic, sticky and prone to precipitation as free compound when exposed to low pH when simulating the passage through the stomach. Thus, the principle of the ionic liquid was combined with the principle of an amorphous solid dispersion. This mitigated the risk of precipitation of the TBPH salt during the passage of the stomach. Also delinquency upon open storage was improved by embedding the TBPH salt in a pH-sensitive polymer. Dissolution tests mimicking the pH gradient in the gastro intestinal tract confirmed the protective properties of the pH-sensitive polymer matrices against recrystallization at low stomach pH in vitro. Furthermore, supersaturation at pH ranges relevant in the intestines of preclinical species or humans was observed. The TBPH solid dispersion showed superior supersaturation behavior in vitro compared to the free acid in pH-sensitive matrix. However, equally increased bioavailability (BAV) was observed when the amorphous solid dispersion contained the free acid form or the TBPH salt. Absorption seemed to be so fast that the short in vitro supersaturation observed for the free from in pH-sensitive matrix was already sufficient for complete absorption within 15 - 30 minutes. This is in accordance with the short tmax of around 15 - 30 minutes after oral application of the low lattice force principles. The pharmacokinetic (PK) profile became the main focus of further optimization as the BAV was maximized already. Early maximal plasma concentration (tmax) went along with high maximal plasma concentration (Cmax) for the low lattice force principles. Central nervous system related side effects as consequence of the PK profile with such a high Cmax were likely to happen and therefore, the formulation principles were modified to maintain the doubled BAV and reduce the observed Cmax. Additionally, the compound showed a short half-life requiring a two times daily dose, which is suboptimal for a chronic treatment. The amorphous acid in pH-matrix showed a modified PK profile when dosed in a hydrogel but not in an oleo gel. Surprisingly, administration of the TBPH salt in pH-matrix suspended in oil showed a massive delay of the tmax to 8 hours and a reduction of Cmax by factor 2 - 3 with unchanged good BAV when administered as a suspension in oil without increased viscosity. TBPH salt solution with a high viscosity resulted in the same PK profile as when administered without increased viscosity.
The animal model was changed from rat to dog. The dose was limited to 15 mg/dog since they reacted much more sensitively to the drug. BAV at this dose level was 100% for the crystalline suspension already, thus the focus of this study was not increasing BAV but to achieve prolonged and/or delayed exposure using different formulation principles elaborated in rats before. An immediate release formulation of 3 mg was combined with a delayed/modified release principle containing 12 mg of the compound. An additional study arm was conducted with a remote controlled device programmed to deliver a first dose of 3 mg instantaneously after passing the stomach and a second dose of 12 mg when entering the caecum. The tmax remained short for all formulation principles and it seemed that delayed and modified release lead to BAV reduction. The modified PK profiles could not be translated to an oral dog model which endorsed the hypothesis of an absorption window; however, the in vitro results could be translated to a dog model for colonic absorption. A nanosuspension of the crystalline compound, the TBPH salt in pH-matrix and the TBPH salt of the pro-drug of the compound were administered rectally to determine colonic absorption. The nanosuspension showed exposure around the limit of quantification whereas the TBPH in pH-matrix showed 4% BAV and the pro-drug as TBPH salt in pH-matrix resulted in 12% BAV although the pro-drug is factor 3 less soluble. This was in line with the increased permeation of the pro-drug which was observed in the Caco2 experiments. The bioavailability was increased by using the low lattice force principles and validated the hypothesis for the acidic drug and its pro-drug in the colonic dog model. Chemical and physicochemical stability of the investigated solid dispersions was confirmed for at least 18 months at room temperature.
Amorphous solid dispersions were investigated to lower lattice forces of a neutral molecule. Solid dispersions are well known from literature; however, they are not frequently used as principles for dosage forms due to limitations in physical stability and complex manufacturing processes. A viable formulation principle was developed for a neutral compound assuming that the stability of a solid dispersion with a drug load below the maximal miscibility will be better than one which exceeds the maximal miscibility. The dispersed and amorphous state of the neutral compound resulted in a higher energy level and chemical potential compared to a crystalline form implying that they are thermodynamically instable and sensitive to recrystallization. This was confirmed by the fast recrystallization of an amorphous solid dispersion made from HPMC with 50% drug load which recrystallized within a few days. Solid dispersions with different drug loads in different polymers and in polymer mixtures were prepared by lyophilization. The miscibility of the compound and the polymer was determined by DSC as the miscibility is a surrogate for maximal stable drugload of the solid dispersion. HPMC was found to be miscible with 20% compound confirming the instability of the 50% HPMC solid dispersion observed earlier. Based on dosing needs, a miscibility/drug load of at least 30% was mandatory because of the dosing requirements to dose less than 1500 mg of final formulation. This was considered as maximal swallowable volume for later clinical development. Thus, all systems with a miscibility higher or equal to 30% drug in polymer were evaluated in an in vitro dissolution test and ranked in comparison with amorphous pure compound, crystalline compound and a 20% drug load solid dispersion made from HPMC. The HPMC based solid dispersion which gave good exposure in previous in vivo experiments did not support the high drugload that was needed. Therefore, similar in vitro behavior of this solid dispersion should result in similar in vivo performance. The polyvinylpyrrolidone (PVP) based solid dispersions scored with high drug load and medium initial kinetic solubility. The Soluplus based solid dispersion offer lower drug load and slightly lower initial kinetic solubility, but showed an extended supersaturation. The 4 best performing systems were evaluated in rats. They resulted in a short Tmax of 15 minutes and BAV higher than 85% indicating fast and complete absorption. The reference HPMC based solid dispersion with a drug load of 20% showed 65% BAV. This showed that higher drug loads were feasible and did not limit absorption in this animal model.
Since the estimated human dose required a higher formulation density than obtained from lyophilization or spray drying, melt extrusion of the solid dispersion was considered to be the most adequate technology. The process temperature needed to be below 200 °C as this value represents the degradation temperature of the polymers. It was investigated by differential scanning calorimetry whether the compound can be mixed with the molten polymer. None of the polymers could dissolve the crystalline compound below the degradation point of the polymer. The temperature had to be increased to 260 °C until the compound was molten together to a monophasic system with polymer. This resulted in degradation of the polymers. Therefore, different plasticizers and small organic molecules with similar functional groups as the compound were investigated on their ability to reduce the melting point of the mixture of polymer and compound. Positive results were obtained with several small molecules. Based on a literature review, nicotinamide had the least concerning pharmaceutical activities and was chosen for further development. Solid dispersions with the same composition as the ones tested in rat were prepared with 9% nicotinamide as softener. Extrusion without nicotinamide was not possible at 135 °C or at 170 °C whereas the addition of 9% nicotinamide led to a homogenous extrudate when processed at 135 °C. The solid state of the extrudates was not molecularly dispersed but the compound was in a crystalline state. They could not reach the in vitro performance observed for the lyophilized solid dispersions with Soluplus or PVP derivatives. Nevertheless, the performances in the supersaturation assay were comparable to the HPMC based lyophilized solid dispersion. The Soluplus and PVP based crystalline extrudates were evaluated in a dog PK showing that the crystalline solid dispersion does not enable BAV higher than 90% within 24 hours after application. In parallel, the hygroscopicity of the meltextrudates was investigated by DVS and the best performing system based on Kollidon VA64 was further optimized regarding the solid state after its extrusion. The minimal process temperature to obtain a fully amorphous solid dispersion was determined by hot stage X-ray powder diffraction analysis (XRPD) and confirmed by lab scale extrusion. Addition of 9% nicotinamide lowered the process temperature from 220 °C (without nicotinamide) to 200 °C with nicotinamide. The minimal temperature for obtaining crystal free material was independent of the nicotinamide amount as soon as it exceeded 9%. Lowering the process temperature with nicotinamide reduced the impurity levels from 3.5% at 220 °C to 1.1% at 200 °C. The fully amorphous extrudates performed now better in the in vitro supersaturation assay than the lyophilized amorphous HPMC solid dispersion and the crystalline extrudates which were extruded at 135 °C. The process was up-scaled to a pilot scale extruder with alternative screw designs increasing mechanical shear forces and mixing which enabled lower process temperatures. This resulted in a maximal process temperature of 195 °C when nicotinamide was present and 205 °C without nicotinamide. However, shorter process time and reduced process temperatures (compared to the lab scale equipment) resulted in impurity levels smaller than 0.5% for both compositions and temperatures and made the nicotinamide obsolete. The amorphous extrudates from the pilot scale extruder performed better in vitro than the crystalline extrudates from the lab scale extruder and the lyophilized HPMC solid dispersion. A comparable PK profile of the HPMC solid dispersion and the amorphous melt extruded formulation principle was anticipated from these in vitro results. This was confirmed by the pharmacokinetic profile in dogs after oral administration of the final extruded solid dispersion formulation which was equivalent with the pharmacokinetic profile of the HPMC based solid dispersion formulation. The assumption that using a drug load below the miscibility prevents the solid dispersion from recrystallization was verified at least for a limited time by a stability test at elevated temperatures for 3 months showing no change in solid state. This indicates the opportunities of the low lattice forces approach, but also showed the importance of developing principles first assuring stable solid state, performance in vitro and in vivo, tailor them in a second step based on performance and combine them with technology such as melt extrusion as third step. If these steps are done in the context of clinical needs and quality it can rationalize the development of a solid dispersion and minimalize the formulation related risks regarding biopharmacy and stability.